Abstract:
An optical fiber includes a silica-based glass portion having an outer diameter of less than about 120 μm. The glass portion comprises a core, an inner cladding and a low index ring. The core comprises an index of refraction n1, and a relative refractive index percent Δ1% relative to pure silica glass. The inner cladding surrounds the core and comprises an index of refraction n2, a radial thickness of less than about 40 μm and a relative refractive index percent Δ2% relative to pure silica glass, wherein Δ1%>Δ2% and the difference between Δ1% and Δ2% is greater than 0.1%. The low index ring surrounds the inner cladding and comprises boron and fluorine, a radial thickness of less than about 20 μm, an index of refraction n3 and a third relative refractive index percent Δ3% relative to pure silica glass, wherein Δ2%>Δ3% and Δ3% is less than −0.5%.
Abstract:
A switchable resistive device has a multi-layer thin film structure interposed between an upper conductive electrode and a lower conductive electrode. The multi-layer thin film structure comprises a perovskite layer with one buffer layer on one side of the perovskite layer, or a perovskite layer with buffer layers on both sides of the perovskite layer. Reversible resistance changes are induced in the device under applied electrical pulses. The resistance changes of the device are retained after applied electric pulses. The selected duration of the electrical pulse is in the range of from about 8 nanosecond to about 100 milliseconds. The selected maximum value of the electrical pulse is in the range of from about 1 V to about 150 V. The electrical pulse may have square, saw-toothed, triangular, sine, oscillating or other waveforms, and may be of positive or negative polarity.
Abstract:
The present disclosure relates to compounds that act as agonists of, or otherwise modulate the activity of, GPR131 and to their use in the treatment of various diseases. In particular embodiments, the structure of the compounds is given by Formula I: wherein the variables are as described herein. Related compositions, formulations and methods for the preparation of compounds of formula I are also described.
Abstract:
A method for producing an optical fiber is provided. The method includes the steps of drawing an optical fiber from a heated glass source in a furnace and introducing index perturbations to the optical fiber via a plurality of perturbation sources arranged at a plurality of different azimuthal locations. The index perturbations are introduced synchronously at different locations along the axial length of the fiber by the plurality of perturbation sources in a generally helical pattern on the outside surface of the fiber in one embodiment. According to another embodiment, the index perturbations are introduced by the plurality of perturbation sources at different frequencies.
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control.
Abstract:
The present invention discloses a method and an apparatus for neighbor cell configuration and a method and an apparatus for femtocell base station configuration. The neighbor cell configuration method includes: obtaining information of at least one macro cell; obtaining neighbor cell information of the at least one macro cell; and performing neighbor cell configuration according to the information of the at least one macro cell and the neighbor cell information. With the method and apparatus for neighbor cell configuration and the method and apparatus for femtocell base station configuration, complete femtocell base station neighbor cell information is obtained so that a femtocell base station can be configured automatically. This avoids call drops during handovers and increases the success rate of handovers, and the implementation is easy.
Abstract:
Self-regulating pressure source. The pressure source includes a chamber enclosing a chemical monopropellant. A moveable boss is attached to a deformable membrane sealing an air chamber, the moveable boss and air chamber being disposed within the chamber. A catalyst is disposed around the membrane so as to be covered by the boss in a retracted position so that the monopropellant is broken down by the catalyst to produce a gas. The gas pressure will increase within the chamber causing air in the air chamber to compress thereby to pull the boss into the retracted position to cover the catalyst thereby to regulate the pressure within the chamber. The self-regulating pressure source is particularly suited to power fluidic elastomeric actuators.
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Abstract:
Aryl GPR119 agonists are provided. These compounds are useful for the treatment of diabetic diseases, including Type II diabetes and other diseases associated with poor glycemic control.
Abstract:
A system for simultaneously determining strain and temperature characteristics of an object comprising: (i) at least one optical fiber having at least two Brillouin peaks; (ii) at least one connector securing the optical fiber to the object to be monitored; (iii) a laser positioned to provide laser light to said at least one optical fiber; (iv) a device measuring frequencies of said at least two Brillouin peaks, and determining frequency shifts of said at least two Brillouin peaks for said at least one optical fiber along the length of fiber; and (v) a system calculating strain and temperature characteristics along said fiber, based on the coefficients of strain and temperature as well as the measured Brillouin frequency shifts for said optical fiber along the length of said optical fiber.